Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06681818

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
125 (estimated)
Sponsor
Englewood Hospital and Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.

Conditions

Interventions

TypeNameDescription
OTHERcarbon monoxide measurement via smokerlyzerparticipants in this study will provide breath samples for carbon monoxide measurements pre and post liver resection

Timeline

Start date
2025-11-21
Primary completion
2039-01-01
Completion
2039-01-01
First posted
2024-11-08
Last updated
2025-07-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06681818. Inclusion in this directory is not an endorsement.